Evidence map›Paper›PMID 27119161›Full record

ArticleJournal of physiology and biochemistry2016

A common effect of angiotensin II and relaxin 2 on the PNT1A normal prostate epithelial cell line.

Kamila Domińska, Tomasz Ochędalski, Karolina Kowalska, Zuzanna E Matysiak-Burzyńska, Elżbieta Płuciennik, Agnieszka W Piastowska-Ciesielska

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of physiology and biochemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Role of Relaxin Signaling in Cancer: A Review.Biochemical pharmacology · 2024
    Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Relaxin and Matrix Metalloproteinase-9 in Angiotensin II-Induced Abdominal Aortic Aneurysms.Circulation journal : official journal of the Japanese Circulation Society · 2017
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kamila DomińskaDepartment of Comparative Endocrinology, Medical University of Lodz, ul. Zeligowskiego 7/9, 90-752, Lodz, Poland. kamila.dominska@umed.lodz.pl.
Tomasz OchędalskiDepartment of Comparative Endocrinology, Medical University of Lodz, ul. Zeligowskiego 7/9, 90-752, Lodz, Poland.
Karolina KowalskaDepartment of Comparative Endocrinology, Medical University of Lodz, ul. Zeligowskiego 7/9, 90-752, Lodz, Poland.
Zuzanna E Matysiak-BurzyńskaDepartment of Comparative Endocrinology, Medical University of Lodz, ul. Zeligowskiego 7/9, 90-752, Lodz, Poland.
Elżbieta PłuciennikDepartment of Molecular Cancerogenesis, Medical University of Lodz, ul. Zeligowskiego 7/9, 90-752, Lodz, Poland.
Agnieszka W Piastowska-CiesielskaDepartment of Comparative Endocrinology, Medical University of Lodz, ul. Zeligowskiego 7/9, 90-752, Lodz, Poland.
Medical University of Lodz · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prostate gland is a part of the male reproductive tract which produces both angiotensin II (Ang II) and relaxin 2 (RLN2). The present study analyzes the effect of both these peptide hormones at concentration 10(-8)M on viability, proliferation, adhesion, migration, and invasion of normal prostate epithelial cells (PNT1A). Improved survival in two- and three-dimensional cell cultures was noted as well as visual changes in colony size and structure in Geltrex™. Stimulatory influence on cell viability of each peptide applied single was lower than in combination. Enhanced survival of PNT1A cells appears to be associated with increased BCL2/BAX messenger RNA (mRNA) expression ratio. Modulation of cell spreading and cell-extracellular matrix adhesion dynamics were also altered as an influence of tested hormone application. However, long-term Ang II and RLN2 effects may lead to an increase of normal prostate cell migration and invasion abilities. Moreover, gelatin zymography revealed that both gelatinases A and B were augmented by Ang II treatment, whereas RLN2 significantly stimulated only MMP-9 secretion. These results support the hypothesis that deregulation of locally secreted peptide hormones such as Ang II and RLN2 may take part in the development of certain cancers, including prostate cancer. Moreover, the observed ability of relaxin 2 to act as a regulator of mRNA expression levels not only LGR7 but also classic angiotensin receptors suggested that renin-angiotensin system and relaxin family peptide system are functionally linked.

Indexed as

ApoptosisGene Expression RegulationAngiotensin IIBasement Membranebcl-2-Associated X ProteinCell AdhesionCell Line, TransformedCell MovementCell ProliferationCell SurvivalHumansMaleMatrix Metalloproteinase 2Matrix Metalloproteinase 9Mucous MembraneProstateAGTR1 protein, humanAngiotensin IIBAX protein, humanbcl-2-Associated X ProteinBCL2 protein, humanMatrix Metalloproteinase 2Matrix Metalloproteinase 9MMP2 protein, humanMMP9 protein, humanProto-Oncogene Proteins c-bcl-2Receptor, Angiotensin, Type 1Receptor, Angiotensin, Type 2Receptors, G-Protein-CoupledReceptors, PeptideRelaxinRLN2 protein, humanRNA, MessengerRXFP1 protein, humanAngiotensin IIPeptide hormones, prostate glandPNT1ARelaxin 2

Identifiers

PMID27119161
OpenAlexW2344176558

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.